Navigation Links
World Biotech API Market Potential Examined in New Topical Study Now Available at MarketPublishers.com
Date:6/20/2012

London, UK (PRWEB) June 20, 2012

The global API market has been advancing at a significant growth rate in recent times and it is likely to register a healthy CAGR of around 8% during 2012-2015, supported by factors such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological innovation to drive HPAPI segment, as well as impressive participation of private players.

Biotech APIs have a very low share in the global API market with synthetic APIs accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech APIs are sure to see a highly prospective market in the future. The branded APIs currently dominate the biotech APIs market; however, with growing patent expiries and advancements in the market structure, the generic APIs will see a rapid growth.

New market research study “Global Biotech API Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Biotech API Market Analysis
Published: June, 2012
Pages: 60
Price: US$ 1,000.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/global_biotech_api_market_analysis.html

The study presents unbiased analysis and forecast for the biotech API market from a global perspective. It analyses the regulatory structure in the API and the biotech API market covering the mandates and guidelines for manufacturing, safety, and good manufacturing practices (GMP). The report also provides elaborate profiles the top companies involved in the biotech API business to gain insights on their overall business, biotech API functioning, recent activities, along with analysis of their strengths and weaknesses. Furthermore, prudent market segmentation and forecasts; the geographic analysis and regulatory overview can also be found in the review.

Companies discussed include: Bayer Pharma AG, Bayer Pharma AG, Boehringer Ingelheim, Hospira, Lonza, Ranbaxy Laboratories, Royal Dsm N.V., Sigma-Aldrich, Teva Active Pharmaceutical Ingredients, Zhejiang Hisun Pharmaceutical Co. Ltd.

Report Contents:

1. Analyst View

2. Research Methodology

3. Biotech Active Pharmaceutical Ingredients - an Introduction

4. Active Pharmaceutical Ingredient - Industry Performance

4.1 Current and Future Market Analysis to 2015
4.2 Branded and Generic APIs
4.3 Synthetic and Biotech APIs

5. Biotech Active Pharmaceutical Ingredients - Industry Performance

5.1 Current and Future Market Analysis to 2015
5.2 Biogeneric and Innovator Biotech APIs
5.3 Key Geographical Markets

6. Regulatory Environment

7. Competitive Landscape

7.1 Bayer Pharma AG
7.1.1 Business Overview
7.1.2 Strengths and Weaknesses
7.1.3 Recent Developments
7.2 Biocon Limited
7.2.1 Business Overview
7.2.2 Strengths and Weaknesses
7.2.3 Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Business Overview
7.3.2 Strengths and Weaknesses
7.3.3 Recent Developments
7.4 Hospira
7.4.1 Business Overview
7.4.2 Strengths and Weaknesses
7.4.3 Recent Developments
7.5 Lonza
7.5.1 Business Overview
7.5.2 Strengths and Weaknesses
7.5.3 Recent Developments
7.6 Ranbaxy Laboratories
7.6.1 Business Overview
7.6.2 Strengths and Weaknesses
7.6.3 Recent Developments
7.7 Royal Dsm N.V.
7.7.1 Business Description
7.7.2 Strengths and Weaknesses
7.7.3 Recent Developments
7.8 Sigma-Aldrich
7.8.1 Business Overview
7.8.2 Strengths and Weaknesses
7.8.3 Recent Developments
7.9 Teva Active Pharmaceutical Ingredients
7.9.1 Business Overview
7.9.2 Strengths and Weaknesses
7.9.3 Recent Developments
7.10 Zhejiang Hisun Pharmaceutical Co. Ltd.
7.10.1 Business Overview
7.10.2 Strengths and Weaknesses
7.10.3 Recent Developments

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2011)
Figure 4-3: Global - Share of Branded and Generic APIs in API Merchant Market (2011)
Figure 4-4: Global - Share of Synthetic and Biotech APIs in API Market (2011)
Figure 5-1: Global - Biotech API Market (Billion US$), 2011-2015
Figure 5-2: Global - Share of Biogeneric and Innovator APIs in Biotech API Market by (2011)
Figure 5-3: Global - Biotech API Market by Country (%), 2011

More new market research reports by the publisher can be found at RNCOS E-Services page.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9623005.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plasma etching pushes the limits of a shrinking world
2. Researching graphene nanoelectronics for a post-silicon world
3. Multidisciplinary team of researchers develop world’s lightest material
4. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
5. Researchers develop one of the worlds smallest electronic circuits
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. The worlds smallest steam engine
9. StemCyte Adds World Class Talent to its North America and Global Operations
10. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
11. U of Toronto experiment named top breakthrough of 2011 by Physics World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
Breaking Biology News(10 mins):